Post-COVID-19 vaccine acute encephalitis in an adult patient: A case report and literature review

Clin Case Rep. 2023 Feb 8;11(2):e6915. doi: 10.1002/ccr3.6915. eCollection 2023 Feb.

Abstract

Several vaccines were approved after COVID-19 pandemic, which have been fast-tracked for emergency use. The short- and long-term safety profile has been an area of concern. We presented a patient with encephalitis followed by hyponatremia who developed hallucination and seizure 1 day after receiving the second dose of Sinopharm vaccine.

Keywords: COVID‐19 vaccine; SADH; Sinopharm BIBP; encephalitis; hyponatremia.

Publication types

  • Case Reports